San Mateo, CA, United States of America

Sihong Zhou

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sihong Zhou. Retrieved from https://idiyas.com/inventor/sihong-zhou-0v7t285m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sihong Zhou: Innovator in Antibody Technology

Introduction

Sihong Zhou is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibody technologies. His work has the potential to impact various therapeutic applications.

Latest Patents

Sihong Zhou holds a patent titled "Anti-Tissue Factor Antibodies and Antibody Conjugates, Compositions Comprising Anti-Tissue Factor Antibodies or Antibody Conjugates, and Methods of Making and Using Anti-Tissue Factor Antibodies and Antibody Conjugates." This patent showcases his expertise in creating advanced antibody-based solutions.

Career Highlights

Currently, Sihong Zhou is associated with Sutro Biopharma, Inc., where he continues to push the boundaries of biopharmaceutical research. His innovative approach has led to the development of novel therapeutic strategies that could enhance patient outcomes.

Collaborations

Sihong Zhou collaborates with talented professionals in his field, including Junhao Yang and Amandeep Kaur Gakhal. These partnerships foster a dynamic environment for research and innovation.

Conclusion

Sihong Zhou's contributions to antibody technology exemplify the spirit of innovation in the biopharmaceutical industry. His work not only advances scientific knowledge but also holds promise for future medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…